Orion Biotech Opportunities Corp.

Orion Biotech Opportunities Corp. (Nasdaq: ORIA) was a special purpose acquisition company focused on the biotechnology and life sciences sector. The vehicle completed its initial public offering in 2021, targeting merger candidates across the healthcare innovation landscape. On May 1, 2023, the company filed a Form 25 with the SEC, initiating the voluntary delisting and withdrawal of its securities from exchange registration under Section 12(b) of the Securities Exchange Act, marking the close of its public-company lifecycle on Nasdaq. Investors and analysts tracking biotech SPAC activity can sign up at SpacDesk for full filing history, deal timelines, and real-time data on ORIA and the broader SPAC universe.